NAD+ Homeostasis Evidence Map: From Cell Biology to Human Claims
NAD+ is both a redox cofactor and a consumed substrate for signaling enzymes. That broad biology is well established, but it does not make…
Updated September 1, 2026Longevity & Bioregulators · Source-reviewed dossier
Source-Reviewed Research Dossier
NAD+ is an endogenous redox cofactor and enzyme substrate central to energy metabolism, DNA repair and signaling. Established NAD biology does not by itself validate intravenous NAD+, anti-aging protocols or a particular catalog formulation.
Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; the current product specification and lot COA control.
Product identity
Literature reference parameters
Identity safeguard Reference identifiers above describe the literature compound record. The supplied form, formula, molecular weight, purity and storage conditions must be verified against the product-specific specification and lot COA.
A target-to-pathway view grounded in the linked research records.
Reported research findings
Reported outcomes are paired with their experimental model and evidence boundary.
A major review described NAD biosynthesis, redox roles and NAD-consuming enzymes across aging and disease research.
Biological centrality is not evidence that supplementation or infusion improves outcomes.
Read the primary studyA 2022 review examined NAD biology and treatment hypotheses in cardiac remodeling and aging.
A focused review of mechanisms and candidate interventions does not validate direct NAD+ administration or general anti-aging outcomes.
Read the primary studyCatalog options
Pack-level catalog data; lot-level controls remain document-specific.
Small-molecule research compound · 100 mg/vial nominal · 10-vial pack · chemical form, identity and assay controlled by lot specification.
Request by lot: CoA, identity and assay summary
Small-molecule research compound · 500 mg/vial nominal · 10-vial pack · chemical form, identity and assay controlled by lot specification.
Request by lot: CoA, identity and assay summary
Small-molecule research compound · 1000 mg/vial nominal · 10-vial pack · chemical form, identity and assay controlled by lot specification.
Request by lot: CoA, identity and assay summary
Document availability is stated honestly and can vary by catalog variant or lot.
Analytical interpretation
Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.
Open the Quality & Documentation HubHPLC area ≠ assayA dominant peak does not establish target mass fraction.
Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.
Counterions affect contentWater, salt form and solvents change the as-is composition.
Storage needs a data basisShipping practice is not the same as stability evidence.
Evidence map
Published studies and regulatory records, not customer testimonials or usage guidance.
Biological centrality is not evidence that supplementation or infusion improves outcomes.
View primary recordA focused review of mechanisms and candidate interventions does not validate direct NAD+ administration or general anti-aging outcomes.
View primary recordThird-party publications selected for direct relevance.
Houtkooper RH, et al. Endocr Rev. 2010. PMID 19149596.
Mini-review. 2022. PMID 35249481.
Concise answers for researchers comparing identity, evidence and catalog variants.
NAD+ is an endogenous redox cofactor and enzyme substrate central to energy metabolism, DNA repair and signaling. Established NAD biology does not by itself validate intravenous NAD+, anti-aging protocols or a particular catalog formulation.
The evidence base strongly supports biological importance, while clinical intervention claims depend on the exact compound, route, exposure and outcome.
No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.
A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.
Store at -20 °C, protected from light and moisture. After reconstitution, aliquot and avoid repeated freeze-thaw cycles. Confirm the applicable storage statement on the product-specific specification and lot documentation.
Knowledge center
Owned educational content connected to this family.
NAD+ is both a redox cofactor and a consumed substrate for signaling enzymes. That broad biology is well established, but it does not make…
Updated September 1, 2026
The plus sign is not decorative: NAD+ is the oxidized form and NADH is the reduced form. Their formulas, spectra, redox behavior and assay…
Updated September 1, 2026Knowledge tools
Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.
Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.
Technical procurement
Selected: NJ100 · 100 mg × 10 vials
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.